Regrettably, the most authoritative source on AIDS has stated that this medication is not a viable solution, and that the only effective preventative measure remains the use of condoms.
A recent study revealed that the research was 100% effective. One may inquire as to what the prior research entailed, but there have been some positive developments reported by The Washington Post: https://www.washingtonpost.com/…-percent-effective/
It is the inaugural and exclusive medication that can be utilized to avert HIV infection, which has been sanctioned by the Food and Drug Administration as of today.
If you are registered as HIV-positive in Turkey, the drug is provided under the guarantee of the state. This drug is used to reduce the risk of HIV transmission, similar to a morning-after pill, but its primary purpose is to reduce the amount of virus in the blood of HIV-positive individuals and maintain it at a certain level. In treatment, it is typically used in conjunction with ekuri hiv medicine.
The recent publication of the New England Journal of Medicine's "Voice" study has revealed that the use of antiretroviral drugs alone is not sufficient for prevention, contrary to what was previously believed. As an expert in this field, I have yet to encounter a convincing article that supports this conclusion.
It is perplexing that no action has yet been taken on such a critical matter, considering that a medicine should be provided free of charge under health insurance so that HIV-negative people can utilize it as a form of protection from the virus.
A pharmaceutical that is purported to have an efficacy rate of up to 78 percent has been discovered.
Gilead, a pharmaceutical company, has produced a drug for HIV/AIDS consisting of a combination of Emtricitabine (Emtriva) and Tenofovir Disoproxil Fumarate (Viread).